GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year EPS Growth History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| EPS Growth(%) | -19.14 | - |
What is the latest EPS Growth ratio of GUFIC BIOSCIENCES ?
| Year | EPS Growth |
|---|---|
| Mar2025 | -19.14 |
| Mar2024 | - |
How is EPS Growth of GUFIC BIOSCIENCES Trending?
| Years | EPS Growth | % Change | |
|---|---|---|---|
| Mar2025 | -19.14 | 0 | |
| Mar2024 | 0 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EPS Growth ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,886.6 Cr | -3.2% | -4.5% | -15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -3.2% |
-4.5% |
-15% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses